New Combination Therapy For Advanced Kidney Cancer

The US FDA has approved sunitinib for adult patients who had undergone removal of kidney affected with renal cell cancer and at high risk for recurrence.

Kidney cancer also called <a href="http://www.medindia.net/patients/patientinfo/renal-cell-carcinoma.htm" target="_blank" class="vcontentshlink" alt="Know About Renal Cell Carcinoma" title="Know About Renal Cell Carcinoma">renal cancer</a> is one of the top 10 most common cancers in both men and women. Kidney cancer mostly affects people above 65 years of age. There are four types of kidney cancer namely renal cell carcinoma, transitional cell carcinoma, Wilms tumor and renal sarcoma.

Renal cell carcinoma is kidney cancer that affects the lining of the kidney tubules. The initial stages of the cancer are asymptomatic and this makes early management of the disease difficult.

Bevacizumab-awwb, a biosimilar to the monoclonal antibody bevacizumab, has received FDA approval for the treatment of several advanced cancers.